These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 33151938

  • 1. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.
    Ndung'u K, Murilla GA, Thuita JK, Ngae GN, Auma JE, Gitonga PK, Thungu DK, Kurgat RK, Chemuliti JK, Mdachi RE.
    PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients.
    Kagira JM, Maina N.
    Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149
    [Abstract] [Full Text] [Related]

  • 3. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN, Matemba L, Kaboya JS, Lubega GW.
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [Abstract] [Full Text] [Related]

  • 4. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
    Dukes P.
    Trans R Soc Trop Med Hyg; 1984 Feb; 78(6):711-25. PubMed ID: 6241967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle.
    Enyaru JC, Matovu E, Lubega GW, Kaminsky R.
    Acta Trop; 1998 Jun; 69(3):261-9. PubMed ID: 9638278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda.
    Mutuku CN, Bateta R, Rono MK, Njunge JM, Awuoche EO, Ndung'u K, Mang'era CM, Akoth MO, Adung'a VO, Ondigo BN, Mireji PO.
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():57-67. PubMed ID: 33588295
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O, Lastre González M, Urban M, Shwalbach J.
    Rev Cubana Med Trop; 1991 Apr; 43(3):189-93. PubMed ID: 9768188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M, Matovu E, Brun R, Kaminsky R.
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [Abstract] [Full Text] [Related]

  • 17. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense.
    Graf FE, Ludin P, Arquint C, Schmidt RS, Schaub N, Kunz Renggli C, Munday JC, Krezdorn J, Baker N, Horn D, Balmer O, Caccone A, de Koning HP, Mäser P.
    Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diminazene aceturate resistance on the virulence of Trypanosoma brucei for rats.
    Egbe-Nwiyi TN, Igbokwe IO, Onyeyili PA.
    J Comp Pathol; 2005 Nov; 133(4):286-8. PubMed ID: 16271938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.